In addition, data from Yuan at al. [39] have shown that the DLC1 promoter is methylated in some of the NSCLC cell lines that do not express DLC1 mRNA, and can be re-activated by treatment with azacytidine. This evidence concerns the gene DLC1 and non-small cell lung carcinoma.